about
Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisThe skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes.The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiensePopulation genomics reveals the origin and asexual evolution of human infective trypanosomes.Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.Tolerance to Trypanosomatids: A Threat, or a Key for Disease Elimination?Interest of tumor necrosis factor-alpha -308 G/A and interleukin-10 -592 C/A polymorphisms in human African trypanosomiasis.Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense.A protocol to improve genotyping of problematic microsatellite loci of Trypanosoma brucei gambiense from body fluids.Identification of Glossina palpalis gambiensis specific salivary antigens: towards the development of a serologic biomarker of human exposure to tsetse flies in West Africa.[Human African trypanosomiasis in mangrove epidemiologic area. Presentation, diagnosis and treatment in Guinea, 2005-2007].Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?Differences in pathogenicity and virulence of Trypanosoma brucei gambiense field isolates in experimentally infected Balb/C miceImmune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
P50
Q33751576-29CC4F23-08A6-4000-9376-937C6E36E53AQ34540864-7044F41B-54B9-479B-96C7-CF15A0A8D9F0Q34796896-C39B36F5-A164-463E-8679-03BBF6B1D058Q35904147-3F85805B-B560-4738-B208-5336CCB80E8DQ38615202-403945D3-411A-4BE2-B942-0AB3A93141A9Q38661478-EDF5694B-0F3D-48A1-806A-C34534A110D7Q38954880-0AF3C7ED-D4E2-4FE2-B037-79A99C012F37Q40595918-87B228EB-6B24-4F9A-9C34-D9A7809981C6Q43923961-51561FE7-E109-425C-84CB-346E13B37F81Q43923974-FD290FEF-B988-42CB-853F-1BF6C7E01986Q43928325-F89C8E8B-5132-4021-BDB6-25A5979CEA8BQ43928690-6976B57D-B5D4-4704-9159-B1ED48152524Q46205049-11EAFEE5-D0F4-4293-814B-2F7EE2D7650FQ48507471-D3B6F803-AC0B-4C2D-ACF6-722E0AE29302Q56334660-3E3E03D5-9DED-4F50-AA7F-2183320C7D56Q91394286-61B66D5F-B7F1-4C0F-95BE-BAF4D3B0DAE1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vincent Jamonneau
@ast
Vincent Jamonneau
@en
Vincent Jamonneau
@es
Vincent Jamonneau
@nl
type
label
Vincent Jamonneau
@ast
Vincent Jamonneau
@en
Vincent Jamonneau
@es
Vincent Jamonneau
@nl
prefLabel
Vincent Jamonneau
@ast
Vincent Jamonneau
@en
Vincent Jamonneau
@es
Vincent Jamonneau
@nl
P106
P21
P31
P496
0000-0001-8427-0769